NNNN
NASD Anbio Biotechnology Class A$3.13 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.13, $0.37 below the day’s high of $3.50
- YTD change
- -89.59%
- vs 20-day SMA
- -40.30%
- vs 200-day SMA
- -83.53%
Price ranges
Price & Performance
-24.02 (-88.47%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 94.4% away from all-time highs of $55.65
- NNNN is down 90% since the beginning of the year
- NNNN is down 89% over the past 12 months
- NNNN is down 44% over the past 1 month
- 0% of all NNNN investors are betting against NNNN
NNNN reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -89.2%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -32.25%
- vs 8-day SMA
- -27.67%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.